Compare IART & CLOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IART | CLOV |
|---|---|---|
| Founded | 1989 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 933.9M | 1.0B |
| IPO Year | 1996 | 2020 |
| Metric | IART | CLOV |
|---|---|---|
| Price | $10.45 | $2.02 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 2 |
| Target Price | ★ $14.83 | $3.35 |
| AVG Volume (30 Days) | 688.6K | ★ 5.4M |
| Earning Date | 05-25-2026 | 06-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 38.03 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,924,308,000.00 |
| Revenue This Year | $4.45 | $41.68 |
| Revenue Next Year | $3.57 | $43.92 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 40.34 |
| 52 Week Low | $10.60 | $1.95 |
| 52 Week High | $24.37 | $3.92 |
| Indicator | IART | CLOV |
|---|---|---|
| Relative Strength Index (RSI) | 36.16 | 39.94 |
| Support Level | N/A | $1.98 |
| Resistance Level | $14.14 | $2.78 |
| Average True Range (ATR) | 0.60 | 0.09 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 4.50 | 23.33 |
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.